[Requirement of DPD deficiency screening before prescription of fluoropyrimidines]
Bull Cancer
.
2018 Apr;105(4):331-332.
doi: 10.1016/j.bulcan.2018.03.001.
[Article in French]
Author
Nicolas Penel
1
Affiliation
1
Centre Oscar-Lambret, département de cancérologie générale, 3, rue Frédéric-Combemale, 59000 Lille, France; Service d'oncologie médicale, hôpital Claude Huriez, CHRU de Lille, 59000 Lille, France. Electronic address: n-penel@o-lambret.fr.
PMID:
29661375
DOI:
10.1016/j.bulcan.2018.03.001
No abstract available
Publication types
Editorial
Comment
MeSH terms
Capecitabine
Dihydropyrimidine Dehydrogenase Deficiency*
Dihydrouracil Dehydrogenase (NADP)
Fluorouracil
Humans
Substances
Capecitabine
Dihydrouracil Dehydrogenase (NADP)
Fluorouracil